Obesity, adipose tissue, and bariatric surgery

Area of Science:

• Metabolic Science
• Obesity Research
• Surgical Intervention

Background:

• Rising global obesity rates contribute to metabolic disorders like type 2 diabetes and cardiovascular disease.
• Obesity involves excessive adipose tissue accumulation and dysfunction, including inflammation and altered angiogenesis.
• Mexico faces a high prevalence of obesity, impacting public health significantly.

Purpose of the Study:

• To review the genetic, microbiome, and molecular factors in obesity development.
• To explore the molecular mechanisms of metabolic changes induced by bariatric surgery.
• To examine the impact of bariatric surgery on weight loss and comorbidity remission.

Main Methods:

• Literature review of genetic factors in obesity.
• Analysis of the role of the intestinal microbiome in metabolic health.
• Examination of adipose tissue remodeling processes (angiogenesis, hypoxia, inflammation).
• Review of molecular changes following bariatric surgery.

Main Results:

• Obesity development is multifactorial, involving genetic predisposition and environmental influences like the gut microbiome.
• Adipose tissue remodeling is a key process in obesity and associated metabolic complications.
• Bariatric surgery demonstrates significant efficacy in sustained weight loss and remission of comorbidities, such as type 2 diabetes.

Conclusions:

• Bariatric surgery offers a successful intervention for morbid obesity, modulating molecular pathways.
• Understanding the molecular underpinnings of obesity and surgical interventions is crucial for effective management.
• Further research into genetic and microbiome interactions can inform obesity treatment strategies.